1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Brain Cancer Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Brain Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Brain Cancer Diagnostics Market Regional Analysis
6.2 North America Brain Cancer Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 North America Brain Cancer Diagnostics Market Forecast Analysis
7. North America Brain Cancer Diagnostics Market Analysis – by Diagnostic Type
7.1 Imaging Test
- 7.1.1 Overview
- 7.1.2 Imaging Test: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Lumbar Puncture
- 7.2.1 Overview
- 7.2.2 Lumbar Puncture: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Biopsy
- 7.3.1 Overview
- 7.3.2 Biopsy: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Molecular Testing
- 7.4.1 Overview
- 7.4.2 Molecular Testing: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Brain Cancer Diagnostics Market Analysis – by Cancer Type
8.1 Acoustic Neuroma
- 8.1.1 Overview
- 8.1.2 Acoustic Neuroma: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Astrocytoma
- 8.2.1 Overview
- 8.2.2 Astrocytoma: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Craniopharyngiomas
- 8.3.1 Overview
- 8.3.2 Craniopharyngiomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Ganglioneuromas
- 8.4.1 Overview
- 8.4.2 Ganglioneuromas: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Glioblastoma Multiforme
- 8.5.1 Overview
- 8.5.2 Glioblastoma Multiforme: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.6 Meningiomas
- 8.6.1 Overview
- 8.6.2 Meningiomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.7 Ependymomas
- 8.7.1 Overview
- 8.7.2 Ependymomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Brain Cancer Diagnostics Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: North America Brain Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Brain Cancer Diagnostics Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Brain Cancer Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 North America Brain Cancer Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
- 10.2.1.1.2 US: North America Brain Cancer Diagnostics Market Breakdown, by Cancer Type
- 10.2.1.1.3 US: North America Brain Cancer Diagnostics Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
- 10.2.1.2.2 Canada: North America Brain Cancer Diagnostics Market Breakdown, by Cancer Type
- 10.2.1.2.3 Canada: North America Brain Cancer Diagnostics Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
- 10.2.1.3.2 Mexico : North America Brain Cancer Diagnostics Market Breakdown, by Cancer Type
- 10.2.1.3.3 Mexico : North America Brain Cancer Diagnostics Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Siemens Healthineers A
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GE Healthcare
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 MDxHealth
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 NantOmics
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Biocept, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Koninklijke Philips N.V
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Canon Medical Systems
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Hitachi, Ltd.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Neusoft Medical Systems
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Brain Cancer Diagnostics Market
